|
CYVAC
R21 MALARIA ANTIGEN
|
SOLUTION; INJECTION
5 MCG/0.5ML
|
Zimbabwe
|
2024/18.2/6711
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
CYVAC
R21 MALARIA ANTIGEN
|
SOLUTION; INJECTION
5 MG/0.5ML
|
Zimbabwe
|
2024/18.2/6710
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
DIPHTHERIA + TETANUS + ALUMINIUM PHOSPHATE
-
|
PARENTERAL ORDINARY VIALS
? 5 LF (? 2 IU) + ? 5 LF (? 40 IU) + ? 1.25 MG/DOSE
|
Uganda
|
NDA/MAL/HDP/9387
|
Registered
|
|
DIPHTHERIA + TETANUS + PERTUSSIS + HEPATITIS B + HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE + ALUMINIUM PHOSPHATE
-
|
PARENTERAL ORDINARY VIALS
? 25 LF (? 30 IU) + ? 2.5 LF (? 40 IU) + ? 16 OU (? 4.0 IU) + ? 10 MCG + ? 10 MCG + ? 1.25 MG/DOSE
|
Uganda
|
NDA/MAL/HDP/9389
|
Registered
|
|
LIVE ATTENUATED BOVINE HUMAN ROTAVIRUS REASSORTANT STRATIN [G1, G2, G3, G4 AND G9]
-
|
ORAL LIQUID ORDINARY DROPS
? 10^5.6 FFU /SEROTYPE PER DOSE (2.0 ML)
|
Uganda
|
NDA/MAL/HDP/11424
|
Registered
|
|
LIVE ATTENUATED BOVINE HUMAN ROTAVIRUS REASSORTANT [G1, G2, G3, G4 AND G9]
-
|
PARENTERAL ORDINARY VIALS
?105.6 FFU / SEROTYPE PER DOSE (2 ML)
|
Uganda
|
NDA/MAL/HDP/10050
|
Registered
|
|
LIVE, ATTENUATED MEASLES VIRUS + LIVE ATTENUATED RUBELLA VIRUS
-
|
PARENTERAL ORDINARY VIALS
NLT 1000 CCID50 + 1000 CCID50 / DOSE
|
Uganda
|
NDA/MAL/HDP/7201
|
Registered
|
|
MENINGOCOCCAL A POLYSACCHARIDE + TETANUS TOXOID
-
|
PARENTERAL ORDINARY DRY VIALS
5µG + 5µG /0.5ML
|
Uganda
|
NDA/MAL/HDP/7432
|
Registered
|
|
PNEUMOCOCCAL SACCHARIDE FOR SEROTYPE 1, 5, 6A, 7F, 9V, 14, 19A, 19F AND 23F + SACCHARIDE FOR SEROTYPE 6B
-
|
PARENTERAL ORDINARY VIALS
(2 MCG OF PNEUMOCOCCAL SACCHARIDE FOR SEROTYPE 1, 5, 6A, 7F, 9V, 14, 19A, 19F AND 23F + 4 MCG OF SACCHARIDE FOR SEROTYPE 6B)/ DOSE
|
Uganda
|
NDA/MAL/HDP/9637
|
Registered
|
|
PNEUMOSIL
PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE 10 VALENT
|
VACCINE
2MCG/0.5ML;4MCG/0.5ML
|
Zimbabwe
|
2025/18.2/7062
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
PNEUMOSIL 0.5ML VACCINE
-
|
INJECTION
|
Botswana
|
BOT2203887
|
Registered/Compliant
|
|
POLIO VIRUS (SABIN)
-
|
ORAL LIQUID ORDINARY LIQUIDS
TYPE - I ?106.0 CCID50 TYPE - III ?105.8 CCID50
|
Uganda
|
NDA/MAL/HDP/9999
|
Registered
|
|
PURIFIED RABIES ANTIGEN (RABIES VIRUS PITMAN-MOORE STRAIN 3218)
-
|
PARENTERAL ORDINARY VIALS
NOT LESS THAN 2.5 I.U / DOSE
|
Uganda
|
NDA/MAL/HDP/7197
|
Registered
|
|
R21 MALARIA VACCINE (RECOMBINANT, ADJUVANTED)
-
|
PARENTERAL ORDINARY VIALS
5µG OF MALARIA ANTIGEN & 50µG OF MATRIX-M1 PER DOSE OF 0.5ML
|
Uganda
|
NDA/MAL/HDP/11230
|
Registered
|
|
RABIES HUMAN MONOCLONAL ANTIBODY (RDNA)
-
|
PARENTERAL ORDINARY VIALS
40 IU/ ML
|
Uganda
|
NDA/MAL/HDP/9634
|
Registered
|
|
RABIVAX-S
RABIES VIRUS ANTIGEN (INACTIVATED)
|
VACCINE
NOT LESS THAN 2.5IU
|
Zimbabwe
|
2025/18.2/7106
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
ROTASIL-LIQUID
ROTAVIRUS VACCINE (LIVE ATTENUATED BOVINE)
|
VACCINE
10⁵∙⁶FFU/2ml
|
Zimbabwe
|
2025/18.2/7196
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
SII BCG VACCINE BP (FREEZE DRIED)
BACILLUS CALMETTE–GUERIN
|
VACCINE
1X10^5; 33X10^5 CFU/0.1ML
|
Zimbabwe
|
2005/18.2/4402
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
SII DIPTHERIA AND TETANUS VACCINE ADSORBED (PAEDIATRIC)
DIPTHERIA; TETANUS (ADSORBED)
|
VACCINE
50; 12LF/ML
|
Zimbabwe
|
96/18.2/3101
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|
|
SII DIPTHERIA-TETANUS-PERTUSSIS VACCINE ADSORBED
DIPTHERIA; PERTUSIS; TETANUS (ADSORBED)
|
VACCINE
50LF; 32IOU; 50LF
|
Zimbabwe
|
96/18.2/3100
|
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
|